Global Insights, Expert Dialogues: JiaLiang Medical's Successful Participation at IESS Concludes as IPO Filing Submitted
GenLight
Innovative Medical Device Solution Provider
The stars shine on those who work hard; though the grand event has ended, exploration continues.
From October 17 to October 19, the 2nd International Epilepsy Surgery Society Congress (IESS) was held in Beijing. Genlight Neurotech, as a strong force focusing on innovative epilepsy diagnosis and treatment, deeply participated in this academic feast, exchanging ideas with many experts and scholars and jointly drawing a blueprint.
Booth Interaction, Extraordinary Heat
Genlight Neurotech became one of the highlights of the conference, attracting a large number of experts from China and abroad to consult on its cutting-edge solutions such as the LaserRO™ MRI-guided Laser Ablation Minimally Invasive Surgical System and the Epilcure™ Implantable Closed-loop Self-responsive Neurostimulation System.
During the conference, through in-depth exchanges with many experts from China and abroad, we gained numerous valuable suggestions in terms of precise positioning, minimally invasive operations, and optimization of therapeutic effects.
Grateful for the Journey, Setting Sail on a New Course
Every gathering is for a better departure. Genlight Neurotech sincerely thanks the IESS Conference for providing a valuable platform, appreciates the insightful contributions of every expert present, and acknowledges the strong support from all partners.
Although the grand event has concluded, Genlight Neurotech's efforts to advance epilepsy diagnosis and treatment in China continue without pause. We will remain committed to the fields of neuromodulation and minimally invasive therapies, serving clinical needs and benefiting patients with more innovative and reliable technical solutions.
